We’re at SABCS with Dr. Gaorav Gupta, who is offering new insight into a question that has long evaded answers: Can immunotherapy be effective in hormone receptor-positive (HR ) breast cancer? Immunotherapy has had some success in triple-negative breast cancer, but not as much in other subtypes. Dr. Gupta’s study tested whether delivering focused radiation w/pembro prior to surgery could create an immune-stimulating signal that makes immunotherapy more effective for HR /HER2- breast cancers. Ear

17K views · 426 reactions | Rachael was with her husband when she was diagnosed with hormone receptor-positive and HER2-positive breast cancer. Hear Rachael’s story of overcoming challenges and building the family she always wanted. | Roche | Facebook